Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02875925 · ClinicalTrials.gov registry record · NA

Outcomes Study of MTM in a Medicare ACO

A NA study of Pain and Hypoglycemia, sponsored by HealthEast Care System.

Completed
Registry status
NA
Development phase
77
Enrollment target
1
Study location

NCT02875925: Completed NA study of Pain and Hypoglycemia, sponsored by HealthEast Care System.

NCT02875925 is a NA study of Pain and Hypoglycemia that has completed, run by HealthEast Care System. The registered enrollment target is 77 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02875925, a NA study of Pain and Hypoglycemia, has completed, sponsored by HealthEast Care System.

COMPLETED
Registry status
NA
Development phase
77 participants
Enrollment target
1
Study location

Study Summary

This is a non-randomized, prospective, quasi-experimental study designed to assess the impact of pharmacist-provided medication management on total cost of care and clinical outcomes (ie, hospitalizations, emergency department visits) in a real-world clinical practice.

Conditions Studied

Interventions

  • OTHER MTM

Study Locations (1)

Minnesota

  • HealthEast Care System - Saint Paul

Trial Details

FieldValue
Enrollment Target 77 participants
Start Date 2015-12
Est. Completion 2017-12
Phase NA
HealthEast Care System

5 total trials

What the finished NCT02875925 record still lists

NCT02875925 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (75% lower).

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which MTM is the first listed.

NCT02875925 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT02875925 about?

NCT02875925 is a clinical study titled "Outcomes Study of MTM in a Medicare ACO". This is a non-randomized, prospective, quasi-experimental study designed to assess the impact of pharmacist-provided medication management on total cost of care and clinical outcomes (ie, hospitalizations, emergency department visits) in a real-world clinical practice.

What is the current status of trial NCT02875925?

This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2015-12. Estimated completion is 2017-12.

What conditions does trial NCT02875925 study?

This clinical trial studies the following conditions: Pain, Hypoglycemia.

What interventions are being tested in trial NCT02875925?

The interventions under investigation include: MTM (OTHER).

Who is sponsoring clinical trial NCT02875925?

This trial is sponsored by HealthEast Care System, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02875925 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02875925's enrollment target sits among peer trials

77 207th of 374 higher than 168 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02127398 · 77 participants · Phase 2

    Stool Transplants to Treat Refractory Clostridium Difficile Colitis

  • NCT04159103 · 77 participants · Phase 1

    Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

  • NCT04683003 · 77 participants · Phase 3

    A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

  • NCT05004116 · 77 participants · Phase 1

    A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02875925, the US trial registry maintained by the National Library of Medicine. NCT02875925 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.